The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.9, 2003-09, pp. : 1501-1509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity

By Kowalski Timothy J McBriar Mark D

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1113-1122

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of oestrogen receptor ligands in development for osteoporosis

By Cho C.H. Nuttall M.E.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 137-154

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands

Current Neuropharmacology, Vol. 6, Iss. 4, 2008-12 ,pp. : 344-366

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists in diabetes

By Chakrabarti S. Cukiernik M. Mukherjee S. Chen S.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2873-2888

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics: potential role in the treatment of diabetes and obesity

By Vella Adrian Camilleri Michael

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1109-1119

Informa Healthcare

Access to resources Recommend Favorite